CME Medical Courses | Healthcare Professional Continuing Education

General CME Courses

Pulmonology CME/CE Courses

myCMEYour search for high-quality, complimentary CME/CE stops right here. The courses below are presented by myCME, the continuing education engine in Haymarket Medical Network’s (HMN) expanding portfolio of clinical websites. Below you’ll find practice-relevant courses that carry valuable CME/CE credit. Simply click any link to get started earning credit on myCME.

Featured Courses

Ideal PAH Patient Care: Bridging the Gap Between Patient and Provider Perceptions

Ideal PAH Patient Care: Bridging the Gap Between Patient and Provider Perceptions

AAPA Category I CME credit, CNE Contact Hour(s), CE for Nurse Practitioner
The goals for the treatment of Pulmonary Arterial Hypertension are to improve the individual’s hemodynamic parameters, delay disease progression, improve exercise tolerance and quality of life, and minimizing mortality risks. This activity reviews the pathophysiology, diagnostic criteria, and classification of pulmonary arterial hypertension.
From Risk Assessment to Treatment: Real-World Approaches to PAH

PAH Expert Commentary

AMA PRA Category 1 Credit(s)TM
In this clinical commentary experts describe risk assessment and treatment selection in PAH, use of oral combination therapy, and practical guidance for overcoming treatment barriers.
EGPA: Facilitating Prompt Recognition and Optimal Treatment

EGPA: Facilitating Prompt Recognition and Optimal Treatment | myCME

AMA PRA Category 1 Credit(s)TM, ANCC Contact Hour(s), AANP Contact Hour(s)
This one-hour activity on EGPA, led by 3 EGPA experts, will address the most current information on the diagnosis, treatment initiation and long-term monitoring of this rare eosinophilic disorder. Faculty will review the clinical manifestations of EGPA from both rheumatologic and pulmonary perspectives, including how EGPA is similar to and differs from other vasculitides.
Improving Outcomes in NTM-LD: Strategies for Diagnosis, Individualized Treatment Plans and Patient Adherence

Improving Outcomes in NTM-LD: Strategies for Diagnosis, Individualized Treatment Plans and Patient Adherence | myCME

AMA PRA Category 1 Credit(s)TM
Nontuberculous mycobacterial (NTM) lung disease is a chronic, progressive illness fraught with long treatments and severe side effects. The majority of NTM patients who have completed treatment can get it again. Research is emerging that may impact best practices in managing and treating patients with NTM along with new American Thoracic Society (ATS)/Infectious Diseases Society of America (IDSA) guidelines. In this program, learn practical tools to diagnose, treat, and manage NTM.
Diagnosis & Treatment of Progressive Fibrosing ILD

Diagnosis & Treatment of Progressive Fibrosing ILD | myCME

AMA PRA Category 1 Credit(s)TM, CNE Contact Hour(s)
Chronic Fibrosing ILD with a Progressive Lung Disease Phenotype (PF-ILD) occurs in multiple, overlapping clinical settings, and differentiating them can be frustrating and fraught with uncertainty. Learn to promptly and accurately diagnose patients with PF-ILD and apply contemporary evidence to treatment decisions.
Individualized Care of Patients with COPD in the Hospital and Beyond

Individualized Care of Patients with COPD in the Hospital and Beyond | myCME

AMA PRA Category 1 Credit(s)TM, CNE Contact Hour(s), CE for Pharmacists
The burden and frequency of hospitalization for chronic obstructive pulmonary disease (COPD) remains high, requiring increased vigilance for changing symptoms and risk factors for exacerbations. It also requires that acute phase, emergency medicine, and inpatient healthcare providers (HCPs) are able to evaluate patient status and provide therapies matched to individual patients’ needs and severity levels.
Can You Identify Patients with NTM? Diagnosis, Treatment & Monitoring

Can You Identify Patients with NTM? Diagnosis, Treatment & Monitoring

AMA PRA Category 1 Credit(s)TM
Nontuberculous mycobacterial (NTM) lung disease is a chronic, progressive illness fraught with long treatments and severe side effects. The majority of NTM patients who have completed treatment can get it again. Research is emerging that may impact best practices in managing and treating patients with NTM along with new American Thoracic Society (ATS)/Infectious Diseases Society of America (IDSA) guidelines. In this program, learn practical tools to diagnose, treat, and manage NTM.

Click for More Pulmonology Courses

Next hm-section-front in General CME Courses